What are the precautions for taking Riluzole?
Patients should pay attention to the occurrence of adverse events such as liver damage, neutropenia, and interstitial pneumonia during treatment with riluzole (Riluzole).
1. Liver damage:
Cases of drug-induced liver injury (fatal) and asymptomatic hepatic transaminase elevations have occurred in patients taking riluzole, with some patients relapsing after re-treatment with riluzole. In pooled studies 1 and 2, approximately 50% and 8% of riluzole-treated patients had at least one increase in ALT levels above the ULN and 3 times the ULN, respectively. Monitor patients for signs and symptoms of liver injury monthly during the first 3 months of treatment and periodically thereafter. Riluzole is not recommended in patients with liver transaminase levels greater than 5 times the ULN. If there is evidence of liver function abnormalities (e.g., elevated bilirubin), riluzole should be discontinued.

2. Neutropenia:
Severe neutropenia (absolute neutrophil count less than 500/mm3) occurred within 2 months before riluzole treatment Advise patients to report febrile illness.
3. Interstitial lung disease:
Interstitial lung disease, including hypersensitivity pneumonitis, has developed in patients taking riluzole. If interstitial lung disease occurs, discontinue riluzole immediately.
The original drug Riluzole has been launched in China and has entered the scope of Class B medical insurance. Specifications The price of 50mg*56 tablets per box may be around 4,000 RMB. The price of the Turkish version of Riluzole’s original drug, 50mg*56 tablets, sold overseas may be around RMB 1,200 per box (the price may fluctuate due to exchange rates). There are also generic drugs produced in other countries. The price of a box of 50mg*30 tablets produced by an Indian pharmaceutical factory may be around RMB 1,300 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs. For specific prices and drug information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)